Risk and management of cardiac disease in kidney and liver transplant recipients

Area of Science:

• Cardiology
• Nephrology
• Hepatology
• Transplantation Medicine

Background:

• Organ transplantation, including kidney and liver, significantly improves outcomes for end-stage diseases.
• Despite transplantation benefits, recipients experience elevated risks of cardiovascular disease (CVD) and related mortality.
• CVD manifests in various forms, including coronary heart disease, heart failure, arrhythmias, valvulopathies, and pulmonary hypertension in transplant patients.

Purpose of the Study:

• To review the pathophysiology of increased CVD risk post-kidney and liver transplantation.
• To discuss the diverse phenotypes of CVD relevant to transplant recipients.
• To emphasize the need for proactive management of cardiovascular risks in this population.

Main Methods:

• Literature review focusing on pathophysiological mechanisms of CVD post-transplantation.
• Analysis of CVD phenotypes and their specific implications for kidney and liver allograft recipients.
• Synthesis of current understanding regarding risk factors and management strategies.

Main Results:

• Transplant recipients face increased CVD risk due to pre-existing factors and post-transplant complications.
• Post-transplant factors contributing to CVD include weight gain, immunosuppressive drugs, dyslipidemia, and de novo diabetes.
• The review details various CVD manifestations and their unique considerations in the transplant context.

Conclusions:

• Kidney and liver transplant recipients are at a heightened risk for developing and dying from cardiovascular diseases.
• A comprehensive understanding of both short- and long-term CVD risks is crucial for post-transplant care.
• A multidisciplinary approach is essential for effectively managing organ-specific CVD risks in kidney and liver transplant patients.